Post by Daiichi Sankyo Japan

Daiichi Sankyo’s CEO Hiroyuki Okuzawa, who also serves as Vice Chair of the Biopharmaceutical CEOs Roundtable (BCR), and other global biopharmaceutical leaders met with Japan’s Prime Minister Sanae Takaichi in Tokyo on May 27 to reinforce the action needed for Japan to grow its leadership in life sciences. The meeting reaffirmed the importance of partnership between government and the pharmaceutical industry to advance shared objectives—supporting better health outcomes, stronger healthcare systems, economic growth and national security. The Biopharmaceutical CEOs Roundtable (BCR) welcomed the opportunity to engage with government leaders on the innovation ecosystem and partnerships needed to strengthen Japan's position as one of the hubs for pharmaceutical innovation. 🔗 Click to learn more : https://lnkd.in/gqvH-q5k